Vitamin and mineral supplements and thyroid cancer: A systematic review

European Journal of Cancer Prevention

Volumn 22, Issue 2, 2013, Pages 158-168

  Zhang, Li Rita ^a   Sawka, Anna M ^b   Adams, Laura ^a   Hatfield, Nicole ^d   Hung, Rayjean J ^a,c  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY OF GUELPH   (Canada)

Author keywords

dietary supplements; etiology; primary prevention; systematic review; thyroid cancer

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA CAROTENE; CALCIUM; CAROTENOID; IODINE; IRON; MAGNESIUM; MINERAL; MULTIVITAMIN; RETINOL; VITAMIN B COMPLEX; VITAMIN D; ZINC;

CANCER PREVENTION; CANCER RISK; DIET SUPPLEMENTATION; EVIDENCE BASED MEDICINE; HUMAN; MINERAL INTAKE; PRIORITY JOURNAL; PROPHYLAXIS; REVIEW; SYSTEMATIC REVIEW; THYROID CANCER; VITAMIN SUPPLEMENTATION;

ANIMALS; ANTIOXIDANTS; DIETARY SUPPLEMENTS; HUMANS; MINERALS; PRIMARY PREVENTION; THYROID NEOPLASMS; VITAMINS;

EID: 84873414412     PISSN: 09598278     EISSN: 14735709     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e32835849b0     Document Type: Review

References (53)

1. Blot WJ, Li JY, Taylor PR, Guo W, Dawsey S, Wang GQ, et al. (1993). Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/ mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 85:1483-1492.
2. Briefel RR, Johnson CL (2004). Secular trends in dietary intake in the United States. Annu Rev Nutr 24:401-431.
3. Burgess JR (2002). Temporal trends for thyroid carcinoma in Australia: An increasing incidence of papillary thyroid carcinoma (1982-1997). Thyroid 12:141-149.
4. Canadian Cancer Society's Steering Committee (2010). Canadian Cancer Statistics 2010. Toronto, Ontario: Canadian Cancer Society
5. Clark LC, Combs GF Jr., Turnbull BW, Slate EH, Chalker DK, Chow J, et al. (1996). Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. JAMA 276:1957-1963.
6. Clark LC, Dalkin B, Krongrad A, Combs GF Jr., Turnbull BW, Slate EH, et al. (1998). Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial. Br J Urol 81:730-734.
7. Colonna M, Grosclaude P, Remontet L, Schvartz C, Mace-Lesech J, Velten M, et al. (2002). Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Eur J Cancer 38:1762-1768.
8. Committee on Diet and Health FaNB, Commission on Life Sciences, National Research Council (1989). Diet and Health. Implications for reducing chronic disease risk. Washington, DC: National Research Council
9. Cook NR, Le IM, Manson JE, Buring JE, Hennekens CH (2000). Effects of betacarotene supplementation on cancer incidence by baseline characteristics in the Physicians' Health Study (United States). Cancer Causes Control 11:617-626.
10. Dal Maso L, Bosetti C, La Vecchia C, Franceschi S (2009). Risk factors for thyroid cancer: An epidemiological review focused on nutritional factors. Cancer Causes Control 20:75-86.
11. Dal Maso L, Lise M, Zambon P, Falcini F, Crocetti E, Serraino D, et al. (2011). Incidence of thyroid cancer in Italy, 1991-2005: Ime trends and age-eriodcohorteffects. Ann Oncol 22:957-963.
12. Davies L,Welch HG (2006). Increasing incidence of thyroid cancer in the UnitedStates, 1973-2002. JAMA 295:2164-2167.
13. Duffield-Lillico AJ, Dalkin BL, Reid ME, Turnbull BW, Slate EH, Jacobs ET, et al. (2003). Selenium supplementation, baseline plasma selenium status and incidence of prostate cancer: An analysis of the complete treatment period of the Nutritional Prevention of Cancer Trial. BJU Int 91:608-612.
14. D'Avanzo B, Ron E, La Vecchia C, Francaschi S, Negri E, Zleglar R (1997). Selected micronutrient intake and thyroid carcinoma risk. Cancer 79: 2186-2192.
15. Edwards BK, Howe HL, Ries LA, Thun MJ, Rosenberg HM, Yancik R, et al. (2002). Annual report to the nation on the status of cancer, 1973-1999, featuring implications of age and aging on U.S. cancer burden. Cancer94:2766-2792.
16. Galanti MR, Hansson L, Bergstrom R,Wolk A, Hjartaker A, Lund E, et al. (1997). Diet and the risk of papillary and follicular thyroid carcinoma: A populationbased case-control study in Sweden and Norway. Cancer Causes Control 8:205-214.
17. Harrison RA, Holt D, Pattison DJ, Elton PJ (2004). Are those in need taking dietary supplements? A survey of 21 923 adults. Br J Nutr 91: 617-623.
18. Haselkorn T, Stewart SL, Horn-Ross PL (2003). Why are thyroid cancer rates so high in southeast asian women living in the United States? The Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev 12: 144-150.
19. Hayat MJ, Howlader N, Reichman ME, Edwards BK (2007). Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12:20-37.
20. Hennekens CH, Buring JE, Manson JE, Stampfer M, Rosner B, Cook NR, et al. (1996). Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 334:1145-1149.
21. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. (2004). The SU.VI.MAX Study: A randomized, placebo-controlled trial of the health effects of antioxidant vitamins and minerals. Arch Intern Med 164:2335-2342.
22. Higgins JPT, Green S (2011). Cochrane handbook for systematic reviews of interventions Version 5.1.0 . In: Higgins JPT, Green S, editors. The Cochrane collaboration. http//: www.cochrane-handbook.org
23. Hirohata T (1976). Radiation carcinogenesis. Semin Oncol 3:25-34.
24. Horn-Ross PL, Morris JS, Lee M,West DW,Whittemore AS, McDougall IR, et al. (2001). Iodine and thyroid cancer risk among women in a multiethnic population: He Bay Area Thyroid Cancer Study. Cancer Epidemiol Biomarkers Prev 10:979-985.
25. Kilfoy BA, Zheng T, Holford TR, Han X, Ward MH, Sjodin A, et al. (2009). International patterns and trends in thyroid cancer incidence, 1973-2002. Cancer Causes Control 20:525-531.
26. Klein EA, Thompson IM, Lippman SM, Goodman PJ, Albanes D, Taylor PR, Coltman C (2001). SELECT: He next prostate cancer prevention trial. Selenum and Vitamin E Cancer Prevention Trial. J Urol 166:1311-1315.
27. Kolonel LN, Hankin JH, Wilkens LR, Fukunaga FH, Hinds MW (1990). An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control 1:223-234.
28. Lee IM, Cook NR, Manson JE, Buring JE, Hennekens CH (1999). Beta-carotene supplementation and incidence of cancer and cardiovascular disease: He Women's Health Study. J Natl Cancer Inst 91:2102-2106.
29. Lind P, Langsteger W, Molnar M, Gallowitsch HJ, Mikosch P, Gomez I (1998). Epidemiology of thyroid diseases in iodine sufficiency. Thyroid 8: 1179-1183.
30. Mack WJ, Preston-Martin S, Bernstein L, Qian D (2002). Lifestyle and other risk factors for thyroid cancer in Los Angeles County females. Ann Epidemiol 12:395-401.
31. Ministry of Health, Labour and Welfare (2003). The National Nutrition Survey in Japan in 2001. Tokyo: Daiichi-shuppan; pp. 67-145.
32. Mirvish SS (1983). The etiology of gastric cancer. Intragastric nitrosamide formation and other theories. J Natl Cancer Inst 71:629-647.
33. Olson JA (1989). Provitamin A function of carotenoids: He conversion of betacarotene into vitamin A. J Nutr 119:105-108.
34. Omenn GS, Goodman GE, Thornquist MD, Balmes J, Cullen MR, Glass A, et al. (1996). Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150-1155.
35. Park SH, Suh EH, Chi JG (1988). A histopathologic study on 1,095 surgically resected thyroid specimens. Jpn J Clini Oncol 18:297-302.
36. Park Y, Leitzmann MF, Subar AF, Hollenbeck A, Schatzkin A (2009). Dairy food, calcium, and risk of cancer in the NIH-AARP Diet and Health Study. Arch Intern Med 169:391-401.
37. Parkin DM, Muir CS,Whelan SL, Gao YT, Fenlay J, Powell J (1993). Cancer incidence in five continents. Lyon, France: International Agency for Research on Cancer
38. Pettersson B, Coleman MP, Ron E, Adami HO (1996). Iodine supplementation in Sweden and regional trends in thyroid cancer incidence by histopathologic type. Int J Cancer 65:13-19.
39. Reinert A, Rohrmann S, Becker N, Linseisen J (2007). Lifestyle and diet in people using dietary supplements: A German cohort study. Eur J Nutr 46:165-173.
40. Reynolds RM, Weir J, Stockton DL, Brewster DH, Sandeep TC, Strachan MW (2005). Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf) 62:156-162.
41. Rock CL (1997). Carotenoids: Biology and treatment. Pharmacol Ther 75:185-197. Rock CL (2007). Multivitamin-multimineral supplements: who uses them? Am J Clin Nutr 85:277S-279S.
42. Ron E, Kleinerman RA, Boice JD Jr., LiVolsi VA, Flannery JT, Fraumeni JF Jr. (1987). A population-based case-control study of thyroid cancer. J Natl Cancer Inst 79:1-12.
43. Rossing MA, Schwartz SM,Weiss NS (1995). Thyroid cancer incidence in Asian migrants to the United States and their descendants. Cancer Causes Control 6:439-444.
44. Sporn MB, Roberts AB (1983). Role of retinoids in differentiation and carcinogenesis. Cancer Res 43:3034-3040.
45. The Alpha-Tocopherol BCCPSG (1994). The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 330:1029-1035.
46. Touvier M, Kesse E, Clavel-Chapelon F, Boutron-Ruault MC (2005). Dual association of beta-carotene with risk of tobacco-related cancers in a cohort of French women. J Natl Cancer Inst 97:1338-1344.
47. Truong T, Rougier Y, Dubourdieu D, Guihenneuc-Jouyaux C, Orsi L, Hemon D, Guenel P (2007). Time trends and geographic variations for thyroid cancer in New Caledonia, a very high incidence area (1985-1999). Eur J Cancer Prev 16:62-70.
48. Virtamo J, Pietinen P, Huttunen JK, Korhonen P, Malila N, Virtanen MJ, et al. (2003). Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: A postintervention follow-up. JAMA 290:476-485.
49. Wells GA, Shea B, O'Connell D, Peterson J,Welch V, Losos M, Tugwell P (2010). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses. Department of Epidemiology and Community Medicine, University of Ottawa, Canada; http://www.ohri.ca/programs/ clinical-epidemiology/oxford.htm
50. Williams ED, Doniach I, Bjarnason O, Michie W (1977). Thyroid cancer in an iodide rich area: A histopathological study. Cancer 39:215-222.
51. World Cancer Research Fund/American Institute for Cancer Research (2007). Food, nutrition, physical activity, and prevention of cancer: A global perspective. Washington DC: AICR
52. Yang CS (1980). Research on esophageal cancer in China: A review. Cancer Res 40:2633-2644.
53. Zhang SM, Cook NR, Albert CM, Gaziano JM, Buring JE, Manson JE (2008). Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: A randomized trial. JAMA 300:2012-2021.